Macrolide compounds endowed with antiinflammatory activity

Details Macrolide compounds endowed with antiinflammatory activity Macrolide compounds endowed with antiinflammatory activity

2003-07-29

2009-02-10

Peselev, Elli (Department: 1623)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C536S007200

Reexamination Certificate

active

07488811

ABSTRACT:
Macrolide compounds lacking cladinose in position 3 having antiinflammatory activity and substantially free of antibiotic properties, pharmaceutically acceptable salts thereof, and pharmaceutical compositions containing them as active ingredient.

REFERENCES:
patent: 3478014 (1969-11-01), Djokic et al.
patent: 3725385 (1973-04-01), Freiberg
patent: 3923784 (1975-12-01), Kierstead et al.
patent: 3928387 (1975-12-01), Kierstead et al.
patent: 4743593 (1988-05-01), Hunt
patent: 5892008 (1999-04-01), Ku et al.
patent: 5969161 (1999-10-01), Bonnet et al.
patent: 6043226 (2000-03-01), Lundy et al.
patent: 6096714 (2000-08-01), Agouridas et al.
patent: 0 254 534 (1988-01-01), None
patent: 0 682 038 (1995-11-01), None
patent: 0 771 564 (1997-05-01), None
patent: 0 775 489 (1997-05-01), None
patent: 0 941 998 (1999-09-01), None
patent: 2 735 694 (1996-12-01), None
patent: 2001 181294 (2001-07-01), None
patent: 92/16226 (1992-10-01), None
patent: 96/18633 (1996-06-01), None
patent: 97/00684 (1997-01-01), None
patent: 99/16779 (1999-04-01), None
patent: 00 42055 (2000-07-01), None
Takizawa, Hajime et al. “Erythromycin Modulates IL-8 Expression in Normal and Inflamed Human Bronchial Epithelial Cells”, Am. J. Respir. Crit. Care Med., vol. 156, pp. 266-271.
Tamaoki, Jun et al. “Macrolide Antibiotics Protect against Endotoxin-Induced Vascular Leakage and Neutrophil Accumulation in Rat Trachea”, Antimicrobial Agents and Chemotherapy, vol. 38, No. 7, pp. 1641-1643 1994.
Suzuki, Tomoko et al. “Erythromycin and Common Cold in COPD”, Chest, vol. 120, pp. 730-733 2001.
Labro, Marie Therese. “Immunomodulatory Actions of Antibacterial Agents”, Clin. Immunother., vol. 6, pp. 454-464 1996.
Faghih, Ramin et al., “Synthesis and Antibacterial Activity of (9S)-9-Dihydroclarithromycin”, Journal of Antibiotics, vol. 43, pp. 1334-1336 1990.
Anderson, Ronald et al. “Membrane-Stabilizing, Anti-Inflammatory Interactions of Macrolides with Human Neutrophils”, Inflammation, vol. 20, No. 6, pp. 693-705 1996.
Stvrtinova, Viera et al. “Inflammation and Fever”, Academic Electronic Press 1995.
Woodward, R.B. et al. “Asymmetric Total Synthesis of Erythromycin. 2. Synthesis of an Erythronolide A Lactone System”, J. Am. Chem. Soc., vol. 103, No. 11, pp. 3213-3215 1981.
Flynn, Edwin H. et al. “Erythromycin. I. Properties and Degradation Studies”, J. Am. Chem. Soc., vol. 76, pp. 3121-3131 1954.
Zunic, Melita et al. “MDP(Lysyl)GDP, a Nontoxic Muramyl Dipeptide Derivative, Inhibits Cytokine Production by Activated Macrophages and Protects Mice from Phorbol Ester- and Oxazolone-Induced Inflammation”, J. Invest. Dermatol., vol. 111, No. 1, pp. 77-82 1998.
Labro, M.T. “Anti-Inflammatory activity of macrolides: a new therapeutic potential?”, Journal of Antimicrobial Chemotherapy, vol. 41, suppl. B, pp. 37-46 1998.
Mikasa, Keiichi et al. “The anti-inflammatory effect of erythromycin in zymosan-induced peritonitis of mice”, Journal of Antimicrobial Chemotherapy, vol. 30, pp. 339-348 1992.
Abdelghaffar, H. et al. “Comparison of various macrolides on stimulation of human neutrophil degranulation in vitro”, Journal of Antimicrobial Chemotherapy, vol. 38, pp. 81-93 1996.
Labro, M.T. et al. “Comparison of the in-vitro effect of several macrolides on the oxidative burst of human neutrophils”, Journal of Antimicrobial Chemotherapy, vol. 24, pp. 561-572 1989.
Konno, Shin-ichi et al. “Inhibition of Human T-Lymphocyte Activation by Macrolide Antibiotic. Roxithromycin”, Life Sciences, vol. 51, pp. PL231-PL236 1992.
Jorgensen, James H. et al. “Antibacterial Susceptibility Tests: Dilution and Disk Diffusion Methods”, Manual of Clinical Microbiology, 7thedition, pp. 1526-1543 1999.
Sigal, Jr. Max V. et al. “Erythromycin. VI. Degradation Studies”, J. Am. Chem. Soc., vol. 78, pp. 388-395 1956.
Miyatake, H. et al. “Erythromycin Reduces the Severity of Bronchial Hyperresponsiveness in Asthma”, Chest, vol. 99, pp. 670-673 1991.
Tamaoki, Jun et al. “Effect of Erythromycin on Endotoxin-Induced Microvascular Leakage in the Rat Trachea and Lungs”, Am. J. Respir. Crit. Care Med., vol. 151, pp. 1582-1588 1995.
Gasc, Jean-Claude et al. “New Ether Oxime Derivatives of Erythromycin A: A Structure-Activity Relationship Study”, Journal of Antibiotics, vol. 44, No. 3, pp. 313-330 1991.
Abdelghaffar, Houria et al. “Erythromycin A-Derived Macrolides Modify the Functional Activities of Human Neutrophils by Altering the Phospholipase D-Phosphatidate Phosphohydrolase Transduction Pathway”, Journal of Immunology, vol. 159, pp. 3995-4005 1997.
Jaffe, Adam et al. “Long-term azithromycin may improve lung function in children with cystic fibrosis”, The Lancet, vol. 351, p. 420 1998.
O'Neil, Maryadele J. et al. “Erythromycin”, The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals, 13thedition, No. 3714, pp. 654-655 2001.
Koyama, Hiroshi et al. “Erythromycin and diffuse panbronchiolitis”, Thorax, vol. 52, pp. 915-918 1997.

Affiliated with

Also associated with

Rating

Macrolide compounds endowed with antiinflammatory activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Macrolide compounds endowed with antiinflammatory activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Macrolide compounds endowed with antiinflammatory activity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4116114